Harbour Investments, Inc. Vaxart, Inc. Transaction History

Harbour Investments, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.7 - $5.28 $1,431 - $2,798	-530 Reduced 25.99%	1,509 $5,000
Q4 2021 Feb 16, 2022	SELL	$5.77 - $7.96 $235,104 - $324,338	-40,746 Reduced 95.23%	2,039 $13,000
Q3 2021 Nov 15, 2021	BUY	$6.67 - $9.8 $2,001 - $2,940	300 Added 0.71%	42,785 $340,000
Q2 2021 Aug 16, 2021	BUY	$5.06 - $10.78 $87,406 - $186,213	17,274 Added 68.52%	42,485 $318,000
Q1 2021 Aug 17, 2021	BUY	$5.64 - $23.33 $142,190 - $588,172	25,211 New	25,211 $153,000

110

37.6M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $73.4M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbour Investments, Inc. with notifications on news.